Literature DB >> 17657616

Neuroinflammatory reactions in experimental gastric ulcer: target for mucosal protection.

K Gyires1.   

Abstract

The effect of different opioids receptor agonists-morphine, DAGO (mu-agonists), DADLE, DPDPE and deltorphin II (delta-agonists)-on gastric mucosal damage induced by either acidified ethanol or acidified aspirin was studied following subcutaneous (sc) administration of these agonists. The results indicate that both mu and delta receptors are involved in gastroprotection. Morphine, DAGO and DADLE, injected intracerebroventricularly, were also effective in both ulcer models. This suggests that gastric cytoprotection can be induced also be central action, since gastric acid secretion is not involved in the pathomechanism of mucosal damage induced by acidified ethanol. Interaction between the opioids and alpha(2)-adrenoceptors in gastroprotection is suggested by the findings that the gastroprotective effect of clonidine (0.09 mumol/kg orally) was antagonized by opioid antagonists. As both naloxone (1.38 mumol/kg sc) and naltrindole (12 mumol/kg sc) exerted antagonist effects, both mu and delta receptors are likely to be involved in presynaptic alpha(2)-receptor-mediated gastroprotection.

Entities:  

Year:  1997        PMID: 17657616     DOI: 10.1007/s10787-997-0034-5

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  40 in total

Review 1.  Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons.

Authors:  S M Crain; K F Shen
Journal:  Trends Pharmacol Sci       Date:  1990-02       Impact factor: 14.819

2.  Antagonism by naltrexone of the hypotension and bradycardia induced by alpha-methyldopa in conscious normotensive rats.

Authors:  P L van Giersbergen; W de Jong
Journal:  J Pharmacol Exp Ther       Date:  1988-01       Impact factor: 4.030

3.  Enkephalin/endorphin-related peptides in antropyloric gastrin cells.

Authors:  L I Larsson; K Stengaard-Pedersen
Journal:  J Histochem Cytochem       Date:  1981-09       Impact factor: 2.479

4.  Naloxone reverses the antihypertensive effect of clonidine.

Authors:  C Farsang; G Kunos
Journal:  Br J Pharmacol       Date:  1979-10       Impact factor: 8.739

5.  Prevention of stress-induced gastric ulcers by mu- and delta-opioid agonists in the rat.

Authors:  G M Scoto; C Parenti
Journal:  J Physiol Paris       Date:  1993

6.  Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury.

Authors:  A Robert; J E Nezamis; C Lancaster; A J Hanchar
Journal:  Gastroenterology       Date:  1979-09       Impact factor: 22.682

7.  Gastric mucosal protection against ulcerogenic factors in the rat mediated by capsaicin-sensitive afferent neurons.

Authors:  P Holzer; W Sametz
Journal:  Gastroenterology       Date:  1986-10       Impact factor: 22.682

8.  Effects of morphine on gastric ulceration, barrier mucus and acid secretion in pylorus-ligated rats.

Authors:  M Del Tacca; C Bernardini; E Corsano; G Soldani; C Rozé
Journal:  Pharmacology       Date:  1987       Impact factor: 2.547

9.  Effect of [D-Met2,Pro5]enkephalinamide on gastric ulceration and transmucosal potential difference.

Authors:  M Till; T Gáti; K Rábai; D Szombath; J I Székely
Journal:  Eur J Pharmacol       Date:  1988-06-10       Impact factor: 4.432

10.  Central and peripheral sites of action for the protective effect of opioids of the rat stomach.

Authors:  S Ferri; R Arrigo-Reina; S Candeletti; G Costa; G Murari; E Speroni; G Scoto
Journal:  Pharmacol Res Commun       Date:  1983-04
View more
  1 in total

1.  Cytoprotective gastric pentadecapeptide BPC 157 resolves major vessel occlusion disturbances, ischemia-reperfusion injury following Pringle maneuver, and Budd-Chiari syndrome.

Authors:  Predrag Sikiric; Anita Skrtic; Slaven Gojkovic; Ivan Krezic; Helena Zizek; Eva Lovric; Suncana Sikiric; Mario Knezevic; Sanja Strbe; Marija Milavic; Antonio Kokot; Alenka Boban Blagaic; Sven Seiwerth
Journal:  World J Gastroenterol       Date:  2022-01-07       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.